Results 181 to 190 of about 468,103 (315)

A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B‐Cell Lymphoma

American Journal of Hematology, EarlyView.
ABSTRACT Mosunetuzumab plus polatuzumab vedotin has shown promising activity versus rituximab plus polatuzumab vedotin (R‐Pola) in patients with relapsed/refractory (R/R) large B‐cell lymphoma (LBCL; NCT03671018). We present results from the Phase II randomized cohort, evaluating subcutaneous mosunetuzumab plus polatuzumab vedotin (Mosun‐Pola), with ...
Julio C. Chavez, Mariana Bastos‐Oreiro, Catherine Diefenbach, Izidore S. Lossos, Nirav Shah, Sarit Assouline, Adam J. Olszewski, Seema Naik, Nilanjan Ghosh, Song Pham, Michael C. Wei, Connie Batlevi, Iris To, Wahib Ead, Sneha Makadia, Elicia Penuel, Jing Jing, Lihua E. Budde   +17 more
wiley   +1 more source

Extracorporeal carbon dioxide removal (ECCO₂R) in post lung transplant patients. [PDF]

J Extra Corpor Technol
Zavala Gómez MN, Chinchilla Lopez E, Garza Trevino R, Borbolla P, Bernal Heinzel S, Lozano Miranda G, Méndez A, Chavarria Martinez U, Wong M, Camacho Ortiz A, Rizo Topete LM, Sánchez Salazar S.   +11 more
europepmc   +1 more source

Lymphatic Abnormalities in Noonan Syndrome Extend Beyond Clinically Apparent Disease

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Lymphatic disease represents a well‐described manifestation of Noonan syndrome (NS), yet the full phenotypic spectrum remains incompletely characterized, especially in asymptomatic individuals. We conducted a cross‐sectional study including 10 individuals with NS (four with peripheral lymphedema and six without) and 10 age‐ and sex‐matched ...
Inger Norlyk Sheyanth, Benjamin Kelly, Sheyanth Mohanakumar, Steffen Ringgaard, Yoav Dori, Irene Kibæk Nielsen, Uffe Birk Jensen, Vibeke Elisabeth Hjortdal   +7 more
wiley   +1 more source

ATS BEAR Cage: 10 years of building education to advance research with innovation, competition, and fun. [PDF]

ATS Sch
Kirkness JP, Howell D, O'Hara VK, Turenne M, Crim C, Patel NM, Fessel JP.   +6 more
europepmc   +1 more source

Phenotype Expansion of Malan Syndrome: New Cases and a Review of the Literature

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Malan syndrome is an ultra‐rare overgrowth syndrome caused by pathogenic variants or deletions in nuclear factor one X (NFIX) located at 19p13.2. Here, we report a comprehensive literature review and phenotyping of known patients with Malan syndrome and present a novel cohort of eight patients.
Alex F. Nisbet, Sylvie A. Adams, Zoe S. Katz, Christal G. Delagrammatikas, Kosuke Izumi, Winifred Sigal, Kim Ventarola, Elaine H. Zackai, Julia E. Reid, Grant T. Liu, Jennifer M. Kalish   +10 more
wiley   +1 more source

Quantitative Imaging Markers on HRCT Predict Rapid Progression and Adverse Events of Patients with Idiopathic Inflammatory Myopathies-Related Interstitial Lung Disease

International Journal of General Medicine
Hongyi Wang,1,2,* Yuhui Qiang,2– 4,* Jianping Wang,3,5 Yifei Ni,1,5 Anqi Liu,1,5 Jie Du,1,5 Yanhong Ren,2 Shiyao Wang,2 Jing Geng,2 Bingbing Xie,2 Min Liu,5 Huaping Dai2 1China-Japan Friendship Hospital (Institute of Clinical Medical ...
Wang H, Qiang Y, Wang J, Ni Y, Liu A, Du J, Ren Y, Wang S, Geng J, Xie B, Liu M, Dai H   +11 more
doaj  

Protocol for the INterstitial lung Disease EXacerbations (INDEX) Study: a retrospective multicentre cohort study. [PDF]

BMJ Open Respir Res
Goodwin AT, Dixon G, White LJ, Virk H, Nadeem I, Saini G, Khan F, Parfrey H, Scotton CJ, Barratt SL, Taylor G, Gibbons M.   +11 more
europepmc   +1 more source

De Novo 2.2 Mb 19q13.42–q13.43 Microdeletion Encompassing U2AF2: Support for a Haploinsufficiency Model

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT U2 small nuclear RNA auxiliary factor 2 (U2AF2) is an essential pre‐mRNA splicing factor involved in the early stages of pre‐mRNA splicing. To date, multiple individuals have been reported with predominantly heterozygous missense variants presenting intellectual disability, speech and motor delays, seizures, hypotonia, and thin or hypoplastic ...
Amanda Toledo, Sarah Araji, Weimin Bi, Seema R. Lalani   +3 more
wiley   +1 more source

Incidence and disease burden of bronchiectasis in systemic lupus erythematosus: a nationwide population-based study in Korea. [PDF]

RMD Open
Min G, Kye DE, Lee H, Eun Y, Kang HK, Choi H, Yang B, Lee H.   +7 more
europepmc   +1 more source

History of Respiratory Medicine in Canada: Pulmonary hypertension

Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
Sanjay Mehta, Namisha Singh, Jamie Myrah, Robert D. Levy   +3 more
openaire   +1 more source